Aegis began coverage on shares of Happiness Biotech Group (NASDAQ:HAPP) in a research report report published on Friday, The Fly reports. The brokerage issued a buy rating on the stock.
Shares of HAPP stock opened at $4.80 on Friday. Happiness Biotech Group has a fifty-two week low of $3.91 and a fifty-two week high of $5.24.
Happiness Biotech Group Company Profile
Featured Article: What are Closed-End Mutual Funds?
Receive News & Ratings for Happiness Biotech Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Happiness Biotech Group and related companies with MarketBeat.com's FREE daily email newsletter.